|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J and Llovet JM: Major achievements
in hepatocellular carcinoma. Lancet. 373:614–616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Whittaker S, Marais R and Zhu AX: The role
of signaling pathways in the development and treatment of
hepatocellular carcinoma. Oncogene. 29:4989–5005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei L, Lu N, Dai Q, Rong J, Chen Y, Li Z,
You Q and Guo Q: Different apoptotic effects of wogonin via
induction of H(2) O(2) generation and Ca(2+) overload in malignant
hepatoma and normal hepatic cells. J Cell Biochem. 111:1629–1641.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dara L, Ji C and Kaplowitz N: The
contribution of endoplasmic reticulum stress to liver diseases.
Hepatology. 53:1752–1763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malhi H and Kaufman RJ: Endoplasmic
reticulum stress in liver disease. J Hepatol. 54:795–809. 2011.
View Article : Google Scholar
|
|
9
|
Xu M, Lu N, Zhang H, Dai Q, Wei L, Li Z,
You Q and Guo Q: Wogonin induced cytotoxicity in human
hepatocellular carcinoma cells by activation of unfolded protein
response and inactivation of Akt. Hepatol Res. 43:890–905. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oakes SA, Lin SS and Bassik MC: The
control of endoplasmic reticulum-initiated apoptosis by the BCL-2
family of proteins. Curr Mol Med. 6:99–109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rong Y and Distelhorst CW: Bcl-2 protein
family members: Versatile regulators of calcium signaling in cell
survival and apoptosis. Annu Rev Physiol. 70:73–91. 2008.
View Article : Google Scholar
|
|
12
|
Zheng CY, Xiao W, Zhu MX, Pan XJ, Yang ZH
and Zhou SY: Inhibition of cyclooxygenase-2 by tetramethylpyrazine
and its effects on A549 cell invasion and metastasis. Int J Oncol.
40:2029–2037. 2012.PubMed/NCBI
|
|
13
|
Wang Y, Fu Q and Zhao W:
Tetramethylpyrazine inhibits osteosarcoma cell proliferation via
downregulation of NF-κB in vitro and in vivo. Mol Med Rep.
8:984–988. 2013.PubMed/NCBI
|
|
14
|
Yu K, Chen Z, Pan X, Yang Y, Tian S, Zhang
J, Ge J, Ambati B and Zhuang J: Tetramethylpyrazine-mediated
suppression of C6 gliomas involves inhibition of chemokine receptor
CXCR4 expression. Oncol Rep. 28:955–960. 2012.PubMed/NCBI
|
|
15
|
Fu YS, Lin YY, Chou SC, Tsai TH, Kao LS,
Hsu SY, Cheng FC, Shih YH, Cheng H, Fu YY and Wang JY:
Tetramethylpyrazine inhibits activities of glioma cells and
glutamate neuro-excitotoxicity: Potential therapeutic application
for treatment of gliomas. Neuro Oncol. 10:139–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin J, Yu C, Yang Z, He JL, Chen WJ, Liu
HZ, Li WM, Liu HT and Wang YX: Tetramethylpyrazine inhibits
migration of SKOV3 human ovarian carcinoma cells and decreases the
expression of interleukin-8 via the ERK1/2, p38 and AP-1 signaling
pathways. Oncol Rep. 26:671–679. 2011.PubMed/NCBI
|
|
17
|
Zhang Y, Liu X, Zuo T, Liu Y and Zhang JH:
Tetramethylpyrazine reverses multidrug resistance in breast cancer
cells through regulating the expression and function of
P-glycoprotein. Med Oncol. 29:534–538. 2012. View Article : Google Scholar
|
|
18
|
Yi B, Liu D, He M, Li Q, Liu T and Shao J:
Role of the ROS/AMPK signaling pathway in
tetramethylpyrazine-induced apoptosis in gastric cancer cells.
Oncol Lett. 6:583–589. 2013.PubMed/NCBI
|
|
19
|
Wang XB, Wang SS, Zhang QF, Liu M, Li HL,
Liu Y, Wang JN, Zheng F, Guo LY and Xiang JZ: Inhibition of
tetramethyl-pyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug
resistant human hepatocellular carcinoma cells. Oncol Rep.
23:211–215. 2010.
|
|
20
|
Cheng XC, Liu XY, Xu WF, Guo XL and Ou Y:
Design, synthesis and biological activities of novel ligustrazine
derivatives. Bioorg Med Chem. 15:3315–3320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ou Y, Dong X, Liu XY, Cheng XC, Cheng YN,
Yu LG and Guo XL: Mechanism of tetramethylpyrazine analogue CXC195
inhibition of hydrogen peroxide-induced apoptosis in human
endothelial cells. Biol Pharm Bull. 33:432–438. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu H, Wei X, Chen L, Liu X, Li S, Liu X
and Zhang X: Tetramethylpyrazine analogue CXC195 protects against
cerebral ischemia/reperfusion injury in the rat by an antioxidant
action via inhibition of NADPH oxidase and iNOS expression.
Pharmacology. 92:198–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen L, Wei X, Hou Y, Liu X, Li S, Sun B,
Liu X and Liu H: Tetramethylpyrazine analogue CXC195 protects
against cerebral ischemia/reperfusion-induced apoptosis through
PI3K/Akt/GSK3β pathway in rats. Neurochem Int. 66:27–32. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Masoud L, Vijayasarathy C,
Fernandez-Cabezudo M, Petroianu G and Saleh AM: Effect of malathion
on apoptosis of murine L929 fibroblasts: A possible mechanism for
toxicity in low dose exposure. Toxicology. 185:89–102. 2003.
View Article : Google Scholar
|
|
25
|
Kuwana T and Newmeyer DD: Bcl-2-family
proteins and the role of mitochondria in apoptosis. Curr Opin Cell
Biol. 15:691–699. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Loeffler M and Kroemer G: The
mitochondrion in cell death control: Certainties and incognita. Exp
Cell Res. 256:19–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Palanca JM, Aguirre-Rueda D, Granell MV,
Aldasoro M, Garcia A, Iradi A, Obrador E, Mauricio MD, Vila J,
Gil-Bisquert A and Valles SL: Sugammadex, a neuromuscular blockade
reversal agent, causes neuronal apoptosis in primary cultures. Int
J Med Sci. 10:1278–1285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hannun YA: Apoptosis and the dilemma of
cancer chemotherapy. Blood. 89:1845–1853. 1997.PubMed/NCBI
|
|
29
|
Chiantore MV, Vannucchi S, Mangino G,
Percario ZA, Affabris E, Fiorucci G and Romeo G: Senescence and
cell death pathways and their role in cancer therapeutic outcome.
Curr Med Chem. 16:287–300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He K, Si P, Wang H, Tahir U, Chen K, Xiao
J, Duan X, Huang R and Xiang G: Crocetin induces apoptosis of
BGC-823 human gastric cancer cells. Mol Med Rep. 9:521–526.
2014.
|
|
31
|
Rao RV, Ellerby HM and Bredesen DE:
Coupling endoplasmic reticulum stress to the cell death program.
Cell Death Differ. 11:372–380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar
|
|
33
|
Huang KF, Zhang GD, Huang YQ and Diao Y:
Wogonin induces apoptosis and down-regulates survivin in human
breast cancer MCF-7 cells by modulating PI3K-Akt pathway. Int
Immunopharmacol. 12:334–341. 2012. View Article : Google Scholar
|
|
34
|
Sui T, Ma L, Bai X, Li Q and Xu X:
Resveratrol inhibits the phosphatidylinositide 3-kinase/protein
kinase B/mammalian target of rapamycin signaling pathway in the
human chronic myeloid leukemia K562 cell line. Oncol Lett.
7:2093–2098. 2014.PubMed/NCBI
|
|
35
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: Rationale and
promise. Cancer cell. 4:257–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamaguchi H and Wang HG: CHOP is involved
in endoplasmic reticulum stress-induced apoptosis by enhancing DR5
expression in human carcinoma cells. J Biol Chem. 279:45495–45502.
2004. View Article : Google Scholar : PubMed/NCBI
|
